BIO-Europe® 2015: Interview with Sander Slootweg, Forbion Capital Partners

November 19, 2015
Sander Slootweg, managing partner at Forbion Captial Partners, speaks to Mike Ward, global director of content for Informa Pharma Insights, at the recent BIO-Europe partnering meeting in Munich, Germany, about the venture capitalist's new EUR 120m+ fund dedicated to life science projects. They discuss geographical focus for the cash, potential companies of interest and successful exit strategies. Find more videos and articles at http://www.partnering360.com/insight For more information on BIO-Europe, visit our webpage: http://www.ebdgroup.com/beu/index.php
Previous Video
BIO-Europe® 2015: Interview with Sean Marett, BioNTech
BIO-Europe® 2015: Interview with Sean Marett, BioNTech

BioNTech chief operating officer, Sean Marett, discusses his company's recent Sanofi immunotherapy deal wit...

Next Video
BIO-Europe® 2015: Interview with Richard Onyett, ADC Therapeutics
BIO-Europe® 2015: Interview with Richard Onyett, ADC Therapeutics

Richard Onyett, business development director of ADC Therapeutics, chats with Mike Ward, global director of...